Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.

Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Domp�� in 1940 and is headquartered in Milan, Italy.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Qingdao Ronghe Tianze Culture Technology Co., Ltd., established on 2015-08-17, Business scope includes design,acting,release:Domestic advertising business;Planning of cultural and artistic exchange activities;Photography and Videography Services;arts and crafts design;computer animation design,painting service,graphic design,3D animation design,handicraft design;Television planning.Photography and camera equipment rental.software development,wholesale,retail:Computer hardware and software(Excluding electronic publications and online games),Trinkets,Daily necessities,Calligraphy,Jewelry,Clothing and shoes,bags,knitted goods,crafts,Daily necessities,Stationery,Toy;Electronic technology research and development and technical consulting,Technical Services,technology transfer;Cultural and artistic exchange planning,Corporate Image Planning,marketing planning;graphic design;Exhibition display service;Beverage shop;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Evotec AS provides marine handling technology to the offshore industry, from design, till engineering, fabrication, installation, commissioning, start up and service. The company is headquartered in Gurskoy, Norway.

Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.

Inflammatory Response Research is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Their initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza. IRR was founded in 2011 and is headquartered in Santa Barbara, California.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. It operates through the IT and New Medicine business divisions. The IT business division offers interactive voice response system which provides consultation, voicemail, automatic guidance, video conferencing, predictive dialing, audiotext, voice processing function, help desk function, collaborative computing, call switching, and call control. The New Medicine business division develops drugs and diagnostic device for the treatment of central nervous system diseases. The company was founded on March 18, 1997 and is headquartered in Seoul, South Korea.

ISTA Pharmaceuticals is a commercial-stage multispecialty pharmaceutical company. It discovers, develops, and markets remedies for diseases and conditions of the eye in the United States. The company offers products to treat allergies and serious diseases of the eye; and therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. The company’s marketed products comprise of BROMDAY, a bromfenac ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions; BEPREVE, a bepotastine besilate ophthalmic solution for ocular itching associated with allergic conjunctivitis; ISTALOL, a timolol maleate ophthalmic solution for the treatment of glaucoma; and VITRASE, a hyaluronidase injection for use as a spreading agent. Its products under development include OTC artificial tear products to treat dry eye and other ocular conditions; PROLENSA, a bromfenac ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain after cataract extractions; T-PRED for steroid responsive inflammation; BEPOMAX and BEPOSONE nasal sprays for treating allergic rhinitis; and Bromfenac Adjunct for age-related macular degeneration. In addition, the company develops iganidipine to enhance ocular nerve blood flow; latanoprost, a prostaglandin for the treatment of glaucoma; and ecabet sodium for the treatment of dry eye. ISTA Pharmaceuticals sells its products to drug wholesalers; retailers and distributors such as chain drug stores, hospitals, clinics, and government agencies; and managed healthcare providers including health maintenance organizations and other institutions. ISTA Pharmaceuticals was founded in 1992 and is headquartered in Irvine, California. As of June 5, 2012, ISTA Pharmaceuticals operates as a subsidiary of Bausch & Lomb Incorporated.

NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada.

Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

VivaCell Biotechnology Espa��a SL is a private company headquartered in Cordoba, Spain. The firm provides biotechnology.

CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.